Maier A,
Fuchsjager M. Preoperative staging of rectal cancer.
Eur J Radiol.
2003 Aug;47(2):89-97.
Watanabe T.
Chemoradiotherapy and adjuvant chemotherapy for rectal cancer.
Int J Clin Oncol.
2008 Dec;13(6):488-97.
Beets-Tan RGH,
Lambregts DMJ,
Maas M,
Bipat S,
Barbaro B,
Curvo-Semedo L et al.
Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.
Eur Radiol.
2018 Apr;28(4):1465-1475.
Maas M,
Nelemans PJ,
Valentini V,
Das P,
Rödel C,
Kuo LJ et al.
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.
Lancet Oncol.
2010;11:835–844.
Maas M,
Beets-Tan RG,
Lambregts DM,
Lammering G,
Nelemans PJ,
Engelen SM et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.
J Clin Oncol.
2011 Dec 10;29(35):4633-40.
Sassen S,
de Booij M,
Sosef M,
Berendsen R,
Lammering G,
Clarijs R et al.
Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol. 2013 Dec;23(12):3440-9.
Mandard AM,
Dalibard F,
Mandard JC,
Marnay J,
Henry-Amar M,
Petiot JF et al.
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma.
Clinicopathologic correlations.
Cancer.
1994;73:2680–2686.
Peng YF,
Yu WD,
Pan HD,
Wang L,
Li M,
Yao YF et al.
Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
World J Gastroenterol.
2015 Feb 14;21(6):1851-6
Santos MD,
Silva C,
Rocha A,
Matos E,
Nogueira C,
Lopes C.
Tumor regression grades: can they influence rectal cancer therapy decision tree? Int J Surg Oncol.
2013;2013:572149.
Suarez J,
Vera R,
Balén E,
Gomez M,
Arias F,
Lera JM et al.
Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis.
2008 Jul;10(6):563-8.
Van der Paardt MP,
Zagers MB,
Beets-Tan RG,
Stoker J,
Bipat S.
Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013 Oct;269(1):101-12.
Lambregts DM,
Vandecaveye V,
Barbaro B,
Bakers FC,
Lambrecht M,
Maas M, et al.
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Ann Surg Oncol.
2011 Aug;18(8):2224-31.
Gang Cai,
Ye Xu,
Ji Zhu,
Wei-Lie Gu,
Shuai Zhang,
Xue-Jun Ma et al.
Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
World J Gastroenterol.
2013 Sep 7; 19(33): 5520–5527.
Lmabrecht M,
Vandecaveye V,
De Keyzer F,
Roels S,
Pennickx F,
Van Cutsem E et al.
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
Int J Radiat Oncol Biol Phys.
2012 Feb 1;82(2):863-70.
Engin G,
Sharifov R,
Gural Z,
Sagam EK,
Saglam S,
Balik E et al.
Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? Diagn Interv Radiol.
2012 Nov-Dec;18(6):574-81
Iannicelli,
E,
Di Pietropalolo M,
Pilozzi E,
Osti MF,
Valentino M,
Masoni L et al.
Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Abdom Radiol (NY).
2016 Oct;41(10):1906-17.
Foti,
PV,
Privitera G,
Piana S,
Palmucci S,
Spatola C,
Bevilacqua E et al.
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy.
Eur J Radiol Open.
2016 Jul 18;3:145-52.
Lambregts DM,
Beets GL,
Maas M,
Curvo-Semedo L,
Kessels AG,
Thywissen T et al.
Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.
Eur Radiol.
2011 Dec;21(12):2567-74.